Dear colleagues,

Due to the current health situation with the COVID 19 coronavirus pandemic, the GOCO Board in conjunction with the Organising Committee of the 28th GOCO Congress have decided to postpone it until next year (date to be determined). It will therefore be organised by the Radiotherapy Oncology Service of the Catalan Institute of Oncology - H. Germans Trias i Pujol

We thank all the speakers and all those who have been preparing papers, as well as the local committee, for all the work done. We are counting on you all for the next year. 


On the other hand, we inform you that as stablished in the statutes, we must do an annual meeting in which, in addition, part of  the board will be renewed. This meeting will take place telematically, probably on the same day scheduled for the congress. In order to make it easier, it is proposed that each service designates a representative, what would make it easier to vote for the renewal of the board. Soon, it will be sent the anouncement of the date, the candidates and the link to the meeting..

Best regards from the GOCO Board

On November 16th, the XXVI Congress of Grup Oncologic Catala-Occita took place in Hospital del Mar of Barcelona. The participation was of 207 attendees, of whom 51 were physicians, 19 physicists, 69 technicians, 6 nurses, 5 professors and 33 students from technician’s schools.

The global theme of this congress has been to discuss the possibilities of new indications in Radiotherapy in the context of new available technologies and new strategies of treatment.

So, from the clinical point of view, the possibilities of Intraoperative Radiotherapy with low energy photon were presented, focussing on lung primary, breast and disseminated non oligometastasic prostate tumours, but in reference to new systemic treatment schedules. In the global sessions, the indication of re-irradiation for prostate, breast and head and neck cancers were considered, as well as the radiotherapy role in the handle of benign proliferative or inflammatory diseases with no response to standard treatments.

From the technological side, tracking systems of prostate with transponders detection and verification systems based on surfaces superposition experiences were shared to be used as a quality control for patient positioning.

In the medical physicist sessions, dual energy tomography, 3D printers uses in radiotherapy for cast and molds experiences were presented. Also the Scripting task group of the Societat Catalana de Física Mèdica explained the uses and possibilities of scripts.

In parallel, the technician sessions were focussed in extreme hypofractionating and the practical side of its application in stereotactic cranial and extracranial anatomical locations.

The level of the more than 40 conferences, presentations and communications exposed was very high, contributing to the satisfaction expressed by the attendees at the end of this edition devoted to boost the expansion of the new indications of radiotherapy to our environment within the pale of our group GOCO.

Thank you very much to all the participants!

"REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY" is publishing soon a Special Volume about Liver SBRT. It is edited by Drs M.Macià and C. Llacer-Moscardó.

We share the volume Index, where you can see the different articles, where great specialists in the matter have participated.

pdfSpecial Issue: 21 Liver SBRT121.55 KB

Biomarkers Under the 4th International Workshop on the treatment of liver and lung metastases in colorectal cancer, organized by the Hospital Universitari Mutua Terrassa, University of Barcelona, ​​has occurred Panitumumab symposium: the value of personalized medicine Amgen and in which participated Dr. Eduardo Diaz-Rubio, head of Medical Oncology University Hospital Clinico San Carlos, Madrid, Dr. Jean-Yves Douillard, the Institut de l'ouest Cancérologie (ICO) René Gauducheu, Nantes, France and Dr. Cristina Nadal Hospital Clínic of Barcelona. During the symposium the results of the PRIME study published in the New England Journal of Medicine on biomarker RAS mutational status, by Dr. Jean-Yves Douillard, first author of the paper were presented. According Douillard, the study shows that "in a patient with metastatic colorectal cancer, the probability that the biomarker is mutated RAS is 50-50".

Read more ...

The diocesan seminary Monte Corban Santander hosted the week of July 28 to 31, the the Medicine course Innovation in oncology. The challenge of functional units, organized by the Catholic University of Valencia "San Vicente Mártir" and the Therapeutic Association in Hematology and Medical Oncology, Hospital Arnau de Vilanova.

During the course fifteen oncologists, pathologists, radiologists, surgeons, psychologists and nurses, who analyzed the advances in detection and early treatment of cancer, considered the leading cause of death in the population under 75 years were cited.

These experts shared care solutions both as resource management, research and training that have enabled significant improvements in survival over the past two decades and the challenges that patients, doctors and managers face today. The sessions, aimed at professionals, with room for both specialists in training as medical students and nurses, were divided according to functional management units tumor pathology, originally driven by the "Comprehensive Cancer Centers" in the United States, where specialists from different areas come together in the treatment of a specific carcinogenic pathology in order to offer the best treatment option individually.

The sessions, led by professor of oncology at VCU and Head of Service in the Hospital Arnau de Vilanova, Dr. Antonio Llombart, focused on units in the breast, lung, digestive and continuing care.

Further information: Catholic University of Valencia